The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Chondros Dimitrios since 2018.
The trader's CIK number is 1739693.
At the time of the last reporting, Chondros Dimitrios was the SVP, Chief Medical Officer of Halozyme Therapeutics, Inc.. (stock ticker symbol HALO).
Also see all insider trading activities at Halozyme Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2019 | HALO | 0 | $0 | 1,328 | $22,177 | 12,717 | $0 |
| 2018 | HALO | 0 | $0 | 0 | $0 | 2,043 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2019-08-03 | HALO | Sale | 1,328 | 16.70 | 22,177 |
| 2019-06-01 | HALO | Option Ex | 2,043 | .00 | 0 |
| 2019-02-22 | HALO | Option Ex | 3,884 | .00 | 0 |
| 2019-02-14 | HALO | Option Ex | 6,790 | .00 | 0 |
| 2018-06-01 | HALO | Option Ex | 2,043 | .00 | 0 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Chondros Dimitrios (SVP, Chief Medical Officer of Halozyme Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.